ArticleAddiction (Abingdon, England)2022
Risk of self-harm or suicide associated with specific drug use disorders, 2004-2016: a population-based cohort study.
Article in Addiction (Abingdon, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Self-harm in individuals with substance use disorders: Predictive factors and risk model.Addiction (Abingdon, England) · 2026Article
- Street ketamine use and differential risk of suicidality among adults in Taiwan.Harm reduction journal · 2025Article
- The annual trend of suicide rates from 2010 to 2021 in patients with cannabis use disorder - a national registry study.Social psychiatry and psychiatric epidemiology · 2025Article
- Single and Unhoused Population at Risk for Self-Inflicted Burn Injury: A Retrospective Analysis of an Urban American Burn Center's Experience.Journal of burn care & research : official publication of the American Burn Association · 2025Article
- Rare but Relevant: Characterizing Self-Inflicted Burn Injuries in the United States.Journal of burn care & research : official publication of the American Burn Association · 2025Review
- Risk and protective factors of deliberate self-harm among individuals with substance use disorder: A qualitative study in Pakistan.Pakistan journal of medical sciences · 2024Article
- Prevalence, distribution, and inequitable co-occurrence of mental ill-health and substance use among gender and sexuality diverse young people in Australia: epidemiological findings from a population-based cohort study.Social psychiatry and psychiatric epidemiology · 2024Article
- Self-Harm and Suicide Rates Before and After an Early Intervention Program for Patients With First-Episode Schizophrenia.JAMA network open · 2024Article
- Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for cannabis.Frontiers in psychiatry · 2024Article
- The role of substance use disorders in the transition from suicide attempt to suicide death: a record linkage study of a Swedish cohort.Psychological medicine · 2024Article
- Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study.Drug and alcohol dependence · 2023Article
- Commentary on Chai et al: Drug use, self-harm, suicide, and use of registry data in epidemiological research.Addiction (Abingdon, England) · 2022Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsDrug use disorders are associated with increased risk of self-harm. Risk differences associated with specific types of drug use disorders are yet to be comprehensively reported. This study aimed to examine the risk of self-harm or suicide associated with different drug use disorders in Hong Kong.
designPopulation-based cohort study.
settingThe Clinical Data Analysis and Reporting System (CDARS) managed by the Hong Kong Hospital Authority.
participantsCases were people ages 10 years or older who visited a hospital Accident and Emergency department between 1 January, 2004 and 31 December, 2016 with any of 10 specific drug use disorders (comprising opioid; ketamine; methamphetamine; sedative, hypnotic, or anxiolytic; amphetamine or related stimulant; cocaine; cannabis; hallucinogen; unspecified or other drug; and polydrug). Each case was matched with two controls, selected from a subset of people in CDARS sharing the same gender, age and psychiatric profile. A total of 8270 cases and 16 540 matched controls were included. MEASUREMENTS: Incidence and adjusted hazard ratio (aHR) of subsequent self-harm or suicide for each specific drug use disorder were estimated.
findingsThe most prevalent drug use disorder was opioid use disorder (2523; 30.51%) and the least prevalent was hallucinogen use disorder (77; 0.93%). The crude incidence of self-harm or suicide ranged from 26.57 (95% CI, 14.23-44.55) per 1000 person-years for cannabis use disorder to 91.97 (77.32-108.37) for polydrug use disorder. The highest risk of self-harm or suicide was observed in ketamine (aHR, 16.36; 95% CI, 11.03-24.29) and opioid (15.97; 10.73-23.23) use disorders.
conclusionsIn Hong Kong, all types of drug use disorders appear to be significantly associated with increased risk of self-harm or suicide, but risk levels vary by type of drug use disorder.
Indexed as
Identifiers
35112757What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.